HomeCompareSCTY vs JNJ

SCTY vs JNJ: Dividend Comparison 2026

SCTY yields 40000.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCTY wins by $5.18024517379999e+22M in total portfolio value
10 years
SCTY
SCTY
● Live price
40000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.18024517379999e+22M
Annual income
$51,548,940,318,215,365,000,000,000,000.00
Full SCTY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SCTY vs JNJ

📍 SCTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCTYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCTY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCTY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCTY
Annual income on $10K today (after 15% tax)
$3,400,000.00/yr
After 10yr DRIP, annual income (after tax)
$43,816,599,270,483,060,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SCTY beats the other by $43,816,599,270,483,060,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCTY + JNJ for your $10,000?

SCTY: 50%JNJ: 50%
100% JNJ50/50100% SCTY
Portfolio after 10yr
$2.590122586899995e+22M
Annual income
$25,774,470,159,107,683,000,000,000,000.00/yr
Blended yield
99.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SCTY
Analyst Ratings
2
Hold
1
Sell
Consensus: Hold
Altman Z
0.1
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCTY buys
0
JNJ buys
0
No recent congressional trades found for SCTY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCTYJNJ
Forward yield40000.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$5.18024517379999e+22M$30.3K
Annual income after 10y$51,548,940,318,215,365,000,000,000,000.00$4,689.40
Total dividends collected$5.178579568047658e+22M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: SCTY vs JNJ ($10,000, DRIP)

YearSCTY PortfolioSCTY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$4,010,700$4,000,000.00$10,592$272.30+$4.00MSCTY
2$1,503,618,552$1,499,327,102.80$11,289$357.73+$1503.61MSCTY
3$526,936,342,129$525,327,470,278.19$12,123$472.89+$526936.33MSCTY
4$172,618,628,820,566$172,054,806,934,488.28$13,141$629.86+$172618628.81MSCTY
5$52,860,672,107,805,460$52,675,970,174,967,450.00$14,408$846.81+$52860672107.79MSCTY
6$15,132,132,379,588,594,000$15,075,571,460,433,242,000.00$16,021$1,151.60+$15132132379588.58MSCTY
7$4,049,462,878,006,525,600,000$4,033,271,496,360,366,000,000.00$18,122$1,588.22+$4049462878006525.50MSCTY
8$1,013,053,710,099,385,500,000,000$1,008,720,784,819,918,400,000,000.00$20,930$2,228.20+$1013053710099385472.00MSCTY
9$236,926,560,546,299,530,000,000,000$235,842,593,076,493,200,000,000,000.00$24,792$3,191.91+$236926560546299510784.00MSCTY
10$51,802,451,737,999,890,000,000,000,000$51,548,940,318,215,365,000,000,000,000.00$30,274$4,689.40+$5.18024517379999e+22MSCTY

SCTY vs JNJ: Complete Analysis 2026

SCTYStock

Monitronics International, Inc., doing business as Brinks Home Security, provides security alarm monitoring and related services to residential and commercial customers in the United States, Canada, and Puerto Rico. It provides monitoring services for alarm signals arising from burglaries, fires, medical alerts, and other events through security systems at customers' premises. The company also offers home automation and life safety services, such as remote activation and control of security systems; support for video monitoring, flood sensors, and automated garage door and door lock capabilities; and thermostat integration services. In addition, it provides hands-free two-way interactive voice communication between its monitoring center and customers; customer and technical support related services to home monitoring systems and home automation services; and do-it-yourself and professional installation security solutions. It serves its customers through a network of authorized dealers. The company was founded in 1994 and is based in Farmers Branch, Texas.

Full SCTY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SCTY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCTY vs SCHDSCTY vs JEPISCTY vs OSCTY vs KOSCTY vs MAINSCTY vs ABBVSCTY vs MRKSCTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.